Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - metoclopramide hydrochloride -

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - metoclopramide hydrochloride (unii: w1792a2rvd) (metoclopramide - unii:l4yeb44i46) - metoclopramide 10 mg - the use of metoclopramide  tablets, usp is recommended for adults only. therapy should not exceed 12 weeks in duration. symptomatic gastroesophageal reflux:  metoclopramide tablets, usp are indicated as short-term (4 to 12 weeks) therapy for adults with symptomatic, documented gastroesophageal reflux who fail to respond to conventional therapy. the principal effect of metoclopramide is on symptoms of postprandial and daytime heartburn with less observed effect on nocturnal symptoms. if symptoms are confined to particular situations, such as following the evening meal, use of metoclopramide as single doses prior to the provocative situation should be considered, rather than using the drug throughout the day. healing of esophageal ulcers and erosions has been endoscopically demonstrated at the end of a 12-week trial using doses of 15 mg q.i.d. as there is no documented correlation between symptoms and healing of esophageal lesions, patients with documented lesions should be monitored endoscopically. diabetic g

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - metoclopramide hydrochloride - tablets - 10 milligram - metoclopramide

Malta - English - Medicines Authority

mercury pharma international limited 4045 kingswood road, city west business park, co, dublin, ireland - metoclopramide hydrochloride - solution for injection - metoclopramide hydrochloride 5 mg/ml - drugs for functional gastrointestinal disorders

United States - English - NLM (National Library of Medicine)

lupin pharmaceuticals,inc. - metoclopramide hydrochloride (unii: w1792a2rvd) (metoclopramide - unii:l4yeb44i46) - metoclopramide 10 mg - metoclopramide orally disintegrating tablets is indicated in adults for the: - treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux disease (gerd) who fail to respond to conventional therapy. - relief of symptoms associated with acute and recurrent diabetic gastroparesis (gastric stasis). limitations of use : metoclopramide orally disintegrating tablets is not recommended for use in pediatric patients due to the risk of developing tardive dyskinesia (td) and other extrapyramidal symptoms and the risk of methemoglobinemia in neonates [see use in specific populations ( 8.4)] metoclopramide orally disintegrating tablets is contraindicated: - in patients with a history of tardive dyskinesia (td) or a dystonic reaction to metoclopramide [see warnings and precautions (5.1, 5.2)]. - when stimulation of gastrointestinal motility might be dangerous (e.g., in the presence of gastrointestinal hemorrhage, mechanical obstruction,

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - metoclopramide hydrochloride monohydrate -

Malta - English - Medicines Authority

syri limited - metoclopramide hydrochloride - oral solution - metoclopramide hydrochloride 5 mg/5ml - drugs for functional gastrointestinal disorders

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - metoclopramide hydrochloride 5 mg/ml - solution for injection - 5 mg/ml - active: metoclopramide hydrochloride 5 mg/ml excipient: citric acid monohydrate hydrochloric acid sodium chloride sodium citrate sodium hydroxide water for injection - adults (20 years and over) · relief of nausea and vomiting associated with migraine, cancer therapy (chemotherapy or radiation), malignant disease, labour, infectious disease and uraemia

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - metoclopramide hydrochloride - tablet - 10 milligram(s) - propulsives; metoclopramide

New Zealand - English - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - metoclopramide hydrochloride monohydrate 5 mg/ml - solution for injection - 5 mg/ml - active: metoclopramide hydrochloride monohydrate 5 mg/ml